Clinical Trial Update: Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 safety study evaluating whether concomitant injections of C-Tb and 2 tuberculin units affect induration responses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• C-Tb
• Tuberculin (2 TU) (tuberculin)

Snippet

Sponsor: Statens Serum Institut | Conditions: Tuberculosis | Phase 2, Phase 3 | Status: COMPLETED